Award
NIH Reporter #1OT2CA278700-01
NextGen - CRI
Recipient
Not specified
Award Amount
$871,168.00
Ceiling
$871,168.00
Awarded
June 22, 2022
Identifier
1OT2CA278700-01
Award for advanced cellular engineering research targeting pediatric cancers, funded by the National Cancer Institute to develop T-cell therapies for pediatric solid tumors.
Description
The project focuses on advanced cellular engineering for pediatric cancers. It involves multiple work packages including target identification, understanding tumor microenvironment, engineering receptors, evaluating engineered T-cells, clinical translation, and data sharing. The funding is provided by the National Cancer Institute, part of the NIH. The project aims to develop effective T-cell therapies for pediatric solid tumors within a decade.